Cervical Cancer Clinical Trials in Philadelphia, Pennsylvania

8 studies are recruiting for cervical cancer in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

   This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-re…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   3 in total

   Run by

   Abramson Cancer Center at Penn Medicine

   See if you can join NCT05758688 on ClinicalTrials.gov

2. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

   Researchers are looking for new ways to treat metastatic cervical cancer. Cervical cancer is cancer in the cervix, the lower part of the uterus (womb). Metastatic means the cancer has spread to other parts of the body. Researchers want to learn about giving the study medicine sacituzumab tirumoteca…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Honickman Center ( Site 5033), Philadelphia, Pennsylvania

   Locations

   174 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07216703 on ClinicalTrials.gov

3. DESTINY-PANTUMOUR04

   This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have no satisfactory alternative treatment options in a real-world…

   Stage

   Not phased

   Ages

   18 to 130

   Site

   Research Site, Philadelphia, Pennsylvania

   Locations

   18 in total

   Run by

   AstraZeneca

   See if you can join NCT07124000 on ClinicalTrials.gov

4. A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

   This study is being done to find out of NRM-823 is safe and can treat participants with locally advanced or metastatic solid tumors.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Normunity Investigational Site, Philadelphia, Pennsylvania

   Locations

   18 in total

   Run by

   Normunity AccelCo, Inc.

   See if you can join NCT07182149 on ClinicalTrials.gov

5. PopSci CHW4CervixHealth

   Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to prom…

   Stage

   Not phased

   Ages

   25 to 65

   Site

   Thomas Jefferson University, Philadelphia, Pennsylvania

   Run by

   Thomas Jefferson University

   See if you can join NCT07336134 on ClinicalTrials.gov

6. A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

   This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

   Locations

   156 in total

   Run by

   GOG Foundation

   See if you can join NCT04831580 on ClinicalTrials.gov

7. Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

   Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   3 in total

   Run by

   Abramson Cancer Center at Penn Medicine

   See if you can join NCT05952141 on ClinicalTrials.gov

8. Reducing Urban Cervical Cancer Disparities

   This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women an…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Thomas Jefferson University, Philadelphia, Pennsylvania

   Locations

   3 in total

   Run by

   Fox Chase Cancer Center

   See if you can join NCT06416150 on ClinicalTrials.gov